These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9297798)

  • 21. Purification of a high molecular weight kininogen from rat plasma.
    Li HC; Back N
    Prep Biochem; 1980; 10(5):561-79. PubMed ID: 7443632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinin release from high molecular weight kininogen by the action of Hageman factor in the absence of kallikrein.
    Wiggins RC
    J Biol Chem; 1983 Jul; 258(14):8963-70. PubMed ID: 6553057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification and characterization of kininogens from sheep plasma.
    Baba SP; Zehra S; Bano B
    Protein J; 2005 Feb; 24(2):95-102. PubMed ID: 16003951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Porcine high molecular weight kininogen: its purification and properties as a thiol proteinase inhibitor as compared to human high molecular weight kininogen.
    Tani Y; Ohkubo I; Higashiyama S; Kunimatsu M; Sasaki M
    Comp Biochem Physiol B; 1987; 88(2):429-41. PubMed ID: 3123124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of human salivary kallikrein: reactivities to human plasma kininogens and proteinase inhibitors.
    Sakamoto W; Yoshikawa K; Uehara S; Nishikaze O
    J Biochem; 1983 Mar; 93(3):833-8. PubMed ID: 6553577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demonstration of the third kininogen in high and low molecular weight kininogens-deficient Brown Norway Katholiek rat.
    Hayashi I; Ino T; Kato H; Iwanaga S; Nakano T; Oh-ishi S
    Thromb Res; 1984 Dec; 36(6):509-16. PubMed ID: 6570369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High molecular weight kininogen: its inability to correct the clotting of kininogen-deficient plasma after cleavage of bradykinin by plasma kallikrein, plasmin or trypsin.
    Chan JY; Movat HZ; Burrowes CE
    Thromb Res; 1979; 14(6):817-24. PubMed ID: 157559
    [No Abstract]   [Full Text] [Related]  

  • 28. Hydrolysis of human high-molecular-mass kininogen by human plasma kallikrein. Proposal of a new model concept for the course of reaction in presence and absence of C1(-)-inhibitor.
    Wiedler J; Dutler H
    Biol Chem Hoppe Seyler; 1987 Sep; 368(9):1203-13. PubMed ID: 3675872
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydrolysis of rat high molecular weight kininogen by purified rat urinary kallikrein: identification of bradykinin as the kinin formed.
    Girolami JP; Alhenc-Gelas F; Dos Reis ML; Bascands JL; Suc JM; Corvol P; Menard J
    Adv Exp Med Biol; 1986; 198 Pt A():137-45. PubMed ID: 3643701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Purification of high molecular weight kininogen and the role of this agent in blood coagulation.
    Saito H
    J Clin Invest; 1977 Sep; 60(3):584-94. PubMed ID: 893664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demonstration of derivation of rat urinary bradykinin from plasma low-molecular-weight kininogen: a study using kininogen-deficient rats.
    Hagiwara Y; Kojima M; Hayashi I; Oh-ishi S
    Biochem Biophys Res Commun; 1994 Nov; 204(3):1219-24. PubMed ID: 7980599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hydroxylated kininogens and kinins.
    Kato H; Enjyoji K
    Agents Actions Suppl; 1992; 38 ( Pt 1)():217-24. PubMed ID: 1334619
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single-step purification of "kallikrein-resistant" kininogen from rat plasma using monoclonal-antibody immunoaffinity chromatography.
    Bedi GS; Back N
    Prep Biochem; 1985; 15(3):159-69. PubMed ID: 3851460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Properties of chemically oxidized kininogens.
    Nieziołek M; Kot M; Pyka K; Mak P; Kozik A
    Acta Biochim Pol; 2003; 50(3):753-63. PubMed ID: 14515155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A convenient large-scale preparation of high molecular weight kininogen from human plasma.
    Dittmann B; Steger A; Wimmer R; Fritz H
    Hoppe Seylers Z Physiol Chem; 1981 Jul; 362(7):919-27. PubMed ID: 7275013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanism of kinin release from human low-molecular-mass-kininogen by the synergistic action of human plasma kallikrein and leukocyte elastase.
    Sato F; Nagasawa S
    Biol Chem Hoppe Seyler; 1988 Sep; 369(9):1009-17. PubMed ID: 3228488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on human high molecular weight (HMW) kininogen. II. Structural change of HMW kininogen by the action of human plasma kallikrein.
    Mori K; Nagasawa S
    J Biochem; 1981 May; 89(5):1465-73. PubMed ID: 6168636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of kininogens in plasma. A functional method based on the cysteine proteinase inhibitor activity.
    Karlsrud TS; Buø L; Aasen AO; Johansen HT
    Thromb Res; 1996 May; 82(3):265-73. PubMed ID: 8732630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Purification and enzyme study of kininogens I and II from human plasma].
    Díaz A; Henriques OB
    Acta Physiol Lat Am; 1976; 26(4):248-53. PubMed ID: 1032268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein.
    Olson ST; Sheffer R; Francis AM
    Biochemistry; 1993 Nov; 32(45):12136-47. PubMed ID: 7692967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.